Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-label, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of Suzetrigine in Healthy Adult Subjects
Conditions
Interventions
Suzetrigine
Suzetrigine
Locations
1
United States
Celerion - Tempe
Tempe, Arizona, United States
Start Date
March 28, 2024
Primary Completion Date
June 19, 2024
Completion Date
June 19, 2024
Last Updated
July 19, 2024
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
NCT07327931
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions